Abstract
The vascular disorders of bone encompass a broad range of disorders ranging from necrosis due to ischemia to hyperemia from coagulopathy. Reducing the vascular supply to the bone, a highly metabolic organ, creates devastating pathology to vulnerable areas, classically affecting the long bone epiphyses in adults and physeal growth plates in children and adolescents. These patients typically present with pain of the affected joint, diminished range of motion, and loss of use of the limb. If the pathology is able to be corrected, then permanent deformity can be avoided. However, permanent deformity and disability may result requiring operative intervention. Coagulopathic disorders commonly affect soft tissue, where recurrent microtrauma to the synovium causes hemarthrosis, to the muscle causes intramuscular hematoma, and to the dura causes spinal epidural hematoma. Untreated hemarthrosis causes cartilage destruction through hematogenous cytokines, producing an erosive and painful arthropathy. Hematomas are generally benign and amenable to nonoperative management unless they produce neurologic compression. After review of this chapter, the learner should be comfortable with the basics of avascular and hypervascular disorders of bone and joint.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Shah KN, Racine J, Jones LC, Aaron RK. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med. 2015;8:201–9.
Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine. 2006;73:500–7.
Brown TD, Baker KJ, Brand RA. Structural consequences of subchondral bone involvement in segmental osteonecrosis of the femoral head. J Orthop Res. 1992;10:79–87.
Bauer TW, Stulberg BN. The histology of osteonecrosis and its distinction from histologic artifacts. In: Schoutens A, Arlet J, Gardeniers JWM, Hughes SPF, editors. Bone circulation and vascularization in normal and pathological conditions. Boston: Springer; 1993. p. 283–92.
Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its clinical implications: an abridged communication. Clin Orthop Relat Res. 1978;(130):47–50.
Liu Y, Li M, Zhang M, Sun K, Wang H, Yuan X, Cai L. Femoral neck fractures: prognosis based on a new classification after superselective angiography. J Orthop Sci. 2013;18:443–50.
Barnes R, Brown JT, Garden RS, Nicoll EA. Subcapital fractures of the femur. A prospective review. J Bone Joint Surg Br. 1976;58:2–24.
Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32:94–124.
Hernigou P, Habibi A, Bachir D, Galacteros F. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am. 2006;88:2565–72.
Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015;6:590–601.
Matos MA, dos Santos Silva LL, Brito Fernandes R, Dias Malheiros C, Pinto da Silva BV. Avascular necrosis of the femoral head in sickle cell disease patients. Ortop Traumatol Rehabil. 2012;14:155–60.
Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ. Procoagulants and osteonecrosis. J Rheumatol. 2003;30:783–91.
Kealey WD, Mayne EE, McDonald W, Murray P, Cosgrove AP. The role of coagulation abnormalities in the development of Perthes’ disease. J Bone Joint Surg Br. 2000;82:744–6.
Kerachian MA, Harvey EJ, Cournoyer D, Chow TYK, Séguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium. 2006;13:237–44.
Ikemura S, Yamamoto T, Motomura G, Iwasaki K, Yamaguchi R, Zhao G, Iwamoto Y. Lipid metabolism abnormalities in alcohol-treated rabbits: a morphometric and haematologic study comparing high and low alcohol doses. Int J Exp Pathol. 2011;92:290–5.
Wang GJ, Sweet DE, Reger SI, Thompson RC. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am. 1977;59:729–35.
Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet. 1987;1:902–6.
Matsuo K, Hirohata T, Sugioka Y, Ikeda M, Fukuda A. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 1988;(234):115–23.
Oinuma K, Harada Y, Nawata Y, Takabayashi K, Abe I, Kamikawa K, Moriya H. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis. 2001;60:1145.
Mucci JM, Rozenfeld P. Pathogenesis of bone alterations in Gaucher disease: the role of immune system. J Immunol Res. 2015;2015:192761. https://doi.org/10.1155/2015/192761.
O’hEireamhoin S, Bayer T, Mulhall KJ. Total hip arthroplasty in mucopolysaccharidosis type IH. Case Rep Orthop. 2011;2011:1–2.
Slobogean GP, Sprague SA, Scott T, Bhandari M. Complications following young femoral neck fractures. Injury. 2015;46:484–91.
Garden RS. Malreduction and avascular necrosis in subcapital fractures of the femur. J Bone Joint Surg Br. 1971;53:183–97.
Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head. J Bone Joint Surg. 2009;91-B:1013–8.
Agarwala S, Shah SB. Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years. J Arthroplast. 2011;26:1128–34.
Cardozo JB, Andrade DMS, Santiago MB. The use of bisphosphonate in the treatment of avascular necrosis: a systematic review. Clin Rheumatol. 2008;27:685–8.
Sen RK. Management of avascular necrosis of femoral head at pre-collapse stage. Indian J Orthop. 2009;43:6–16.
Wang C-J, Wang F-S, Huang C-C, Yang KD, Weng L-H, Huang H-Y. Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am. 2005;87:2380–7.
Kim S, Kim D, Park I, Park B, Kim P, Ihn J. Multiple drilling compared with standard core decompression for the treatment of osteonecrosis of the femoral head. Orthop Proc. 2004;86-B:149.
Shannon BD, Trousdale RT. Femoral osteotomies for avascular necrosis of the femoral head. Clin Orthop Relat Res. 2004;418:34.
Garino JP, Steinberg ME. Total hip arthroplasty in patients with avascular necrosis of the femoral head: a 2- to 10-year follow-up. Clin Orthop Relat Res. 1997;(334):108–15.
Xenakis TA, Beris AE, Malizos KK, Koukoubis T, Gelalis J, Soucacos PN. Total hip arthroplasty for avascular necrosis and degenerative osteoarthritis of the hip. Clin Orthop Relat Res. 1997;341:62.
Harreld KL, Marker DR, Wiesler ER, Shafiq B, Mont MA. Osteonecrosis of the humeral head. J Am Acad Orthop Surg. 2009;17:11.
Hettrich CM, Boraiah S, Dyke JP, Neviaser A, Helfet DL, Lorich DG. Quantitative assessment of the vascularity of the proximal part of the humerus. JBJS. 2010;92:943.
Buijze GA, Ochtman L, Ring D. Management of scaphoid nonunion. J Hand Surg Am. 2012;37:1095–100.
Lutsky K, Beredjiklian PK. Kienböck disease. J Hand Surg Am. 2012;37:1942–52.
Kattapuram TM, Kattapuram SV. Spontaneous osteonecrosis of the knee. Eur J Radiol. 2008;67:42–8.
Zaremski JL, Vincent KR. Spontaneous osteonecrosis of the knee. Curr Sports Med Rep. 2016;15:228.
Narváez J, Narváez JA, Rodriguez-Moreno J, Roig-Escofet D. Osteonecrosis of the knee: differences among idiopathic and secondary types. Rheumatology (Oxford). 2000;39:982–9.
Ecker ML, Lotke PA. Spontaneous osteonecrosis of the knee. JAAOS. 1994;2:173.
Cebesoy O, Karakurum G. Talar fractures and avascular necrosis. Are we underestimating the risk? Int Orthop. 2007;31:269.
Dhillon MS, Rana B, Panda I, Patel S, Kumar P. Management options in avascular necrosis of talus. Indian J Orthop. 2018;52:284–96.
Murphey MD, Foreman KL, Klassen-Fischer MK, Fox MG, Chung EM, Kransdorf MJ. From the radiologic pathology archives imaging of osteonecrosis: radiologic-pathologic correlation. Radiographics. 2014;34:1003–28.
Resnick D, Niwayama G. Diagnosis of bone and joint disorders. 2nd ed. Philadelphia: Saunders; 1988.
Siffert RS. The osteochondroses. Clin Orthop Relat Res. 1981;(158):10–8.
Anthony S, Munk R, Skakun W, Masini M. Multiple epiphyseal dysplasia. JAAOS. 2015;23:164.
Kim HKW. Legg-Calvé-Perthes disease. JAAOS. 2010;18:676.
Dillman JR, Hernandez RJ. MRI of Legg-Calvé-Perthes disease. Am J Roentgenol. 2009;193:1394–407.
Conway JJ. A scintigraphic classification of Legg-Calvé-Perthes disease. Semin Nucl Med. 1993;23:274–95.
Wyseure T, Mosnier LO, von Drygalski A. Advances and challenges in hemophilic arthropathy. Semin Hematol. 2016;53:10–9.
Pulles AE, Mastbergen SC, Schutgens REG, Lafeber FPJG, van Vulpen LFD. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacol Res. 2017;115:192–9.
Luck JVJ, Silva M, Rodriguez-Merchan CE, Ghalambor N, Zahiri CA, Finn RS. Hemophilic arthropathy. JAAOS. 2004;12:234.
Luck JJ, Kasper CK. Surgical management of advanced hemophilic arthropathy. An overview of 20 years’ experience. Clin Orthop Relat Res. 1989;(242):60–82.
Petrini P, Lindvall N, Egberg N, Blombäck M. Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediatr Hematol Oncol. 1991;13:280–7.
Al-Mutair A, Bednar DA. Spinal epidural hematoma. J Am Acad Orthop Surg. 2010;18:494–502.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shapiro, J.A. (2021). Vascular Disorders of Bone. In: Esther, R.J. (eds) Clinical Foundations of Musculoskeletal Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-42894-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-42894-5_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42893-8
Online ISBN: 978-3-030-42894-5
eBook Packages: MedicineMedicine (R0)